Board of Directors
Chairman of the Board
Dr. Douglas M Hansell
Dr Hansell has experience in large company MedDevice, healthcare startups, biotech & venture capital. Prior to Baxter, Dr. Hansell led the medical strategy that helped Cheetah Medical grow from startup to acquisition by Baxter in 4 years. Prior to Cheetah, Dr. Hansell was Chief Medical Officer for GE Healthcare and Covidien (Medtronic). Prior to industry, Dr. Hansell was CMO of an IDN in Boston. Alongside industry, he has a 30+ year academic career at Massachusetts General Hospital and Harvard Medical School in Boston.
Dr. Alan Levy
He then established and led multiple medical device companies, including Heartstream, that developed the first small, lightweight and easy-to-use automated external defibrillator.
Dr. Levy has also served as a Senior Advisor at Frazier Healthcare Ventures. He currently serves on the boards of multiple private and public healthcare companies.
Dr. Levy holds a BSc in Chemistry from City College of New York and a PhD and Honorary DSc from Purdue University.
Josep Ll. Sanfeliu
Previously Josep has worked in the pharmaceutical industry as Corporate Development Director at Almirall where he was involved with business development and in charge of M&A and corporate investments and also worked as General Manager leading operations in the segment of home-healthcare services at DomusVi.
In addition to his role as Board Member at Medasense Biometrics Ltd., Mr. Weinstein holds director or investor roles in various ventures in the pharmaceutical and healthcare industries, including Olive Tree Ventures, Vanterra and Davidson & W. He is a board member of Health Hero, Atida, Medneo GmbH, Grupo Procaps and Gauzy Ltd.
Mr. Weinstein received a Business and Administration degree from the Universidad Catolica de Chile and is a certified public auditor and accountant. He also a graduate of the OPM program at Harvard Business School.
He has a proven track record of launching over 300 products in the pharmaceutical industry in Latin America and completing more than 20 licensing deals including biotech products and medical devices. He currently serves as a Board Member of Convexity Scientific, Via Surgical and Dog Parker. He previously served on the board of BMRC, a biotech research consortium in Chile.
Galit Zuckerman Stark
Founder, CEO and board member
Before founding Medasense she led algorithm teams at Applied Materials and worked at Nokia-Siemens and Nice Systems. Galit started her technology career at the elite Israeli Defense Forces “Haman Talpiot” program. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.
Galit holds an MSc degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a BSc in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel Aviv University, Israel.
Dr. Shmuel Cabilly
Today there are already twenty drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more. Dr. Cabilly was also a co-founder and a chief scientist of Ethrog Biotechnology where he invented major technologies in the field of chemistry.
Mr. Gavshon was a significant shareholder in, and served as an Executive Director of private and listed companies which developed icon brands. He has gained broad business experience in Australasia, USA and Asia and has been involved in a number of successful equity ventures where he has also taken Board and advisory roles.
Mr. Gavshon is widely respected for the extensive community service he has given and occupied leading positions in the Australian not-for-profit sector. He holds commerce and law degrees from the University of Witwatersrand, South Africa.